How does fingolimod (gilenya®) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?

  • Franz Fazekas
  • , Ovidiu Bajenaru
  • , Thomas Berger
  • , Tanja Hojs Fabjan
  • , Alenka Horvat Ledinek
  • , Gábor Jakab
  • , Samuel Komoly
  • , Tetiana Kobys
  • , Jörg Kraus
  • , Egon Kurča
  • , Theodoros Kyriakides
  • , L'ubomír Lisý
  • , Ivan Milanov
  • , Tetyana Nehrych
  • , Sergii Moskovko
  • , Panayiotis Panayiotou
  • , Saša Šega Jazbec
  • , Larysa Sokolova
  • , Radomír Taláb
  • , Latchezar Traykov
  • Peter Turčáni, Karl Vass, Norbert Vella, Nataliya Voloshyná, Eva Havrdová

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number10
JournalFrontiers in Neurology
Volume4 MAY
DOIs
Publication statusPublished - 2013

Keywords

  • Algorithm
  • Expert opinion
  • Fingolimod
  • Multiple sclerosis
  • Treatment

Cite this